MedPharm to investigate potency in a wide range of cannabis products

9w
3m read
Summary

Among experienced cannabis consumers, 77.5 per cent of people surveyed prefer low-THC flower to high-THC cannabis concentrates. Volkow wrote, in an environment where there are an ever-increasing number of cannabis products and weed potency continues to rise. Using weed at a younger age could mean faster development of substance use disorders It’s not all about potency: What should cannabis consumers look for in their weed? U.S.-based MedPharm hopes to shed light on whether or not cannabis users from members of the public to researchers are getting what they think they’re getting when it comes to weed potency. MedPharm reported Tuesday that Colorado state has awarded the company a research grant allowing it begin to evaluating cannabis potency as part of a three-year study, which it calls the first of its kind.

Article Preview

U.S.-based MedPharm hopes to shed light on whether or not cannabis users from members of the public to researchers are getting what they think they’re getting when it comes to weed potency.

MedPharm reported Tuesday that Colorado state has awarded the company a research grant allowing it begin to evaluating cannabis potency as part of a three-year study, which it calls the first of its kind.

Investigators will evaluate and compare cannabinoid product label claims to the actual cannabinoid content of the product, notes...

Read the full article @ The Growth Op